Literature DB >> 22123351

The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants.

Karen A McQueen1, Jodie Murphy-Oikonen, Keri Gerlach, William Montelpare.   

Abstract

PURPOSE: To determine whether neonatal abstinence scores of infants exposed to methadone in utero differed by infant feeding method.
DESIGN: A retrospective chart review.
SUBJECTS: Twenty-eight term infants that were exposed to methadone in utero and exhibited symptoms of neonatal abstinence syndrome (NAS) prior to hospital discharge were included into the study. The sample was further divided by self-selected infant feeding method including (1) predominately breastfed (n = 8), combination fed (n = 11) or predominately formula fed (n = 9).
METHODS: Data were extracted by two independent researchers from both the mother's and infant's chart. This included variables such as NAS scores, NAS treatment, infant feeding method and baseline demographic information. MAIN OUTCOME MEASURES: NAS scores were assessed by Registered Nurses according to hospital protocol using a Modified Finnegan Scoring Tool. PRINCIPAL
RESULTS: A non-parametric Kruskal-Wallis one way analysis of variance based on ranks revealed statistically significant differences in the number of NAS scores recorded (P = 0.001), magnitude (P < 0.0001) and area score (P = 0.04) by infant feeding method. In particular, infants who were predominantly breastfed had significantly fewer NAS scores done and lower mean scores suggesting decreased severity and duration of NAS symptoms when compared to infants who were combination fed or predominately formula fed.
CONCLUSION: Breastfeeding may offer enhanced benefits for infants who have been exposed to methadone in utero. As such, in the absence of contraindications, mothers in methadone maintenance programs should be encouraged and supported to breastfeed their infants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22123351     DOI: 10.1097/ANC.0b013e318225a30c

Source DB:  PubMed          Journal:  Adv Neonatal Care        ISSN: 1536-0903            Impact factor:   1.968


  25 in total

Review 1.  ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015.

Authors:  Sarah Reece-Stremtan; Kathleen A Marinelli
Journal:  Breastfeed Med       Date:  2015-04       Impact factor: 1.817

Review 2.  Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS).

Authors:  A K Mangat; G M Schmölzer; W K Kraft
Journal:  Semin Fetal Neonatal Med       Date:  2019-02-05       Impact factor: 3.926

3.  Optimizing Pregnancy Treatment Interventions for Moms (OPTI-Mom): A Pilot Study.

Authors:  Gerald T Cochran; Valerie Hruschak; Walitta Abdullah; Elizabeth Krans; Antoine B Douaihy; Stephanie Bobby; Rachel Fusco; Ralph Tarter
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

Review 4.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

5.  Wide Variation Found in Care of Opioid-Exposed Newborns.

Authors:  Debra L Bogen; Bonny L Whalen; Laura R Kair; Mark Vining; Beth A King
Journal:  Acad Pediatr       Date:  2016-11-23       Impact factor: 3.107

6.  Hepatitis C Virus Knowledge Among Pregnant Women with Opioid Use Disorder.

Authors:  Elizabeth E Krans; Scott D Rothenberger; Penelope K Morrison; Seo Young Park; Leah C Klocke; Mary J Turocy; Susan Zickmund
Journal:  Matern Child Health J       Date:  2018-08

Review 7.  Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.

Authors:  Erin Kelty; David B Preen
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

8.  A pilot multisite study of patient navigation for pregnant women with opioid use disorder.

Authors:  Gerald Cochran; Marcela C Smid; Elizabeth E Krans; M Aryana Bryan; Adam J Gordon; Brad Lundahl; John Silipigni; Benjamin Haaland; Ralph Tarter
Journal:  Contemp Clin Trials       Date:  2019-11-12       Impact factor: 2.226

Review 9.  Pharmacologic management of the opioid neonatal abstinence syndrome.

Authors:  Walter K Kraft; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-08-30       Impact factor: 3.278

10.  Neonatal Abstinence Syndrome Severity Index Predicts 18-Month Neurodevelopmental Outcome in Neonates Randomized to Morphine or Methadone.

Authors:  Tess Flannery; Jonathan M Davis; Adam J Czynski; Lynne M Dansereau; Erica L Oliveira; Samantha A Camardo; Barry M Lester
Journal:  J Pediatr       Date:  2020-08-14       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.